Partnerships & Alliances
Filter News
Found 36,909 articles
-
Universal Cells will get $9 million upfront and is eligible to regulatory milestones payments of up to $115 million, as well as royalties.
-
Nicox Enters Research Collaboration With Re-Vana Therapeutics on its Next Generation of Stand-Alone NO-donors in a Novel Sustained Release Ophthalmic Formulation
10/20/2017
The deal combines Nicox's next generation of stand-alone nitric oxide-donors with Re-Vana's EyeLief long-acting photo-crosslinked biodegradable drug delivery platform for the reduction of intraocular pressure.
-
Fabric Genomics Partners to Improve Pediatric Care
10/20/2017
Fabric Genomics has partnered with Genomics England’s 100,000 Genomes Project, Rady Children’s Institute for Genomic Medicine (RCIGM), and The Utah Genome Project (UGP), to provide fast and accurate identification of pediatric disease-causing variants to improve the clinical care of children.
-
DCPrime and apceth Biopharma GmbH Announce Manufacturing Partnership
10/20/2017
DCPrime BV and apceth Biopharma GmbH, an established contract manufacturing organization in the field of gene and cell therapy, report today that they have entered into a strategic manufacturing agreement.
-
Corrona and the National Multiple Sclerosis Society Announce Intent to Collaborate on a Multiple Sclerosis Registry to Study the Comparative Effectiveness and Safety of Approved Therapies
10/20/2017
Corrona and the National Multiple Sclerosis Society have announced their intent to collaborate on the launch of the MS Registry to study the comparative safety and effectiveness of approved MS therapies.
-
Bio-Tissue Announces Strategic Agreement With Optima Pharmazeutische GmbH to Distribute Its Natural Ocular Cleanser in Germany
10/20/2017
The agreement supports efforts to bring Bio-Tissue’s natural ocular cleanser formulated with 4-Terpineol, Cliradex.
-
Misonix Enters into $11M License, Royalty and Manufacturing Agreement
10/20/2017
The agreement calls for (i) upfront technology license fees and stocking orders of $5 million; (ii) minimum royalty payments from the sale of SonaStar products.
-
Cerveau Technologies Signs Research Agreement With Columbia University Medical Center
10/20/2017
Cerveau Technologies Inc. today announced an agreement with Columbia University Medical Center in New York, New York to support multiple projects over the next several years.
-
AMRA and BioTelemetry Research Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials
10/20/2017
AMRA and BioTelemetry Research Announced today the formation of an exclusive alliance for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) clinical trials.
-
Vivek Ramaswamy's parent company, Roivant Sciences, inked a development deal with Astra.
-
Shares of Arcturus are up nearly 15 percent in Thursday morning trading after the company inked a collaboration agreement with Janssen Pharma to develop a hepatitis B drug program.
-
Abzena and UGA Biopharma Partner to Develop a Cell Line Expressing a Biosimilar Therapeutic for M...
10/19/2017
The partnership centered around the development of an NS0 (murine myeloma) manufacturing cell line, expressing a high quality, fully biosimilar antibody therapeutic. -
Pharmazz has Received Exclusive License to U.S. Patent for Treatment of Opioid Tolerance And Pain Management
10/19/2017
Pharmazz has received exclusive license to U.S. patent for treatment of opioid tolerance and pain management. Inadequate pain control is a major public health concern in the USA.
-
Quotient Clinical Signs Agreement With Nuformix to Evaluate Cocrystal Formulations Using Translational Pharmaceutics
10/19/2017
Under the deal, Quotient will use its Translational Pharmaceutics platform to develop a formulated oral NXP001 cocrystal product and validate its performance in healthy subjects.
-
Boehringer Ingelheim Partners With TARGET PharmaSolutions to Progress NASH Research
10/19/2017
TARGET PharmaSolutions is pleased to announce that Boehringer Ingelheim has entered into a multi-year strategic partnership for TARGET-NASH.
-
Napo Pharmaceuticals Endorses Prevention Access Campaign's U=U Consensus Statement for People Living With HIV/AIDS (PLWHA)
10/19/2017
Napo Pharmaceuticals announced today that it has joined more than 400 organizations from 59 countries in supporting the U=U Consensus Statement.
-
RPRD Diagnostics Partners with St. Jude Children's Research Hospital to Offer Comprehensive Pharmacogenetics Testing
10/19/2017
RPRDDiagnostics, a privately-held, Wisconsin-based precision medicine company, today announced a collaboration with St. Jude Children's Research Hospital.
-
Insulet And Dexcom Partner To Offer Choices For Animas Users
10/19/2017
Insulet is partnering with DexCom, Inc. (Dexcom) to provide the Omnipod System and a $200 gift card from Dexcom which can be used towards the purchase of a Dexcom G5 Mobile CGM (Continuous Glucose Monitoring) for qualified Animas insulin pump users.
-
Edico Genome and Fabric Genomics Develop Integrated Solution For Genomic Analysis With the Goal of Improving Clinical Care
10/19/2017
Today at the ASHG Annual Meeting, Edico Genome and Fabric Genomics announced their collaboration to provide an integrated solution for secondary and tertiary analysis of next-generation sequencing data.
-
Healthe and Corning Announce Collaboration on Technology to Help Protect Against Digital Device Blue Light Exposure
10/19/2017
Healthe and Corning Incorporated announce their collaboration to develop and introduce Eyesafe technology made with Accessory Glass 2 by Corning.